Yakira Capital Management, Inc. Zynerba Pharmaceuticals, Inc. Transaction History

Yakira Capital Management, Inc.

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 13, 2023	BUY	$0.33 - $1.39 $204,606 - $861,826	620,019 New	620,019 $787,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Yakira Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Yakira Capital Management, Inc. with notifications on news.